Get 50% OFF This Monsoon!
Global Longlife Hospital and Research
No Data Available
Investor Sentiment
Global Longlife Hospital and Research Share price and Fundamental Analysis
Key Metrics
Stock Returns
Stock Heatmap
No Stocks
Smart Score
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
Technicals
Returns Calculator
If you would have investedResearch Report
No Research Report
Corporate Action
Financials
Key Ratios
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
Dividend History
Global Longlife Hospital and Research Competitors
5 Year FactSheet
Documents
No Data Available
News
Global Longlife Hospital and Research Management and History
Company Management
Unlock Management Data
See Detailed Analysis & Insights
Company History
Global Longlife Hospital and Research Limited was originally incorporated as 'Global Longlife Hospital and Research Private Limited' as a Private Limited Company on January 20, 2012 issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently, Company was converted into a Public Limited Company and consequently, name of the Company was changed to 'Global Longlife Hospital and Research Limited' vide fresh Certificate of Incorporation dated August 31, 2021.
Mr. Suresh Jani along with the team of doctors and the investors have incorporated the Company to bring healthcare of international standards within the reach of every individual. The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in the month of March 2012, within approximately two months from the incorporation of the Company. The Promoter with the help of the Doctor team had completed the Hospital within a period of three years and started hospital in the year 2015-16. Mr. Dhruv Jani had also joined the hospital business with his father in the month of July 2015.The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017. At present the Promoters along with his family members hold 81.43 % stake in the Company.
The Company is known as a Multi Speciality Tertiary Care Hospital of Gujarat with 110 beds well equipped for Medical & Surgical Specialities. As a policy, any doctor having experience of more than 3 years can admit his patient in the hospital. The Company provide platform to the doctors for treatment of their patients. Apart from the 11 full time consultants, the Hospital has a team of more than 30 experienced doctors as a consultant to serve patients. Its staff strength comprises 37 nursing staff and more than 50 paramedical, corporate and support staff and pharmacists.
The Company has invested in, and established a IT system both for clinical purposes as well as integrating systems and processes through HMS (Hospital Management System) which includes Central Registration Module, Appointment, Barcode Generation, Case Paper Generation, OPD Billing, Procedure billing, IPD Registration, Advance & Refund, Due billing, TPA/Package Billing, User Management, Doctor Sharing, Software Security, Management Reports, Discharge Summary towards streamlining clinical and administrative functions. The Company also adopted technology to ensure quick transmission of disease data, subsequent analysis, and prompt disease management.
Hospital business mainly depends on the skills of Medical Practitioners and the quality of services provided by the healthcare staff members. Apart from the Full time doctors, the Hospital has a well experienced team of consultants of various field of medicines to provide the quality healthcare services to the patients. The dedicated team is trained to take care of the patients and handle all kinds of emergencies. Its healthcare staff members comprise of Medical Director, Quality Manager, Clinical Pharmacist, Microbiologist, Medical Officers, Clinical Assistants, Infection Control Nurse, Nursing staff, Attendants, Paramedical staff, Dietician/ Nutritionist, Medical Transcriber, Biomedical Engineers and etc. who all are well trained for their services toward its patients.
The Hospital provide comprehensive healthcare services across a range of specialties and super-specialties. These include Cardiology, Allergy and immunology, oncology, Diabetes & Endocrinology, Anesthesiology, Pain Management, Internal Medicine , Nephrology, Neurology, Dermatology, plastic Surgery and others. The hospital has been awarded 'The Best Emerging Hospital' by Times of India. It offer various health care services at affordable prices.
The Company came up with Initial Public Issue of 35,00,000 Equity Shares of Face value of Rs. 10/- each, aggregating to Rs. 49 crores and the resultant, the Company' Shares got listed on May 04, 2022 on SME Platform of BSE Limited.
Global Longlife Hospital and Research Share Price
Global Longlife Hospital and Research share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Global Longlife Hospital and Research Market Cap
Market capitalization of Global Longlife Hospital and Research indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Global Longlife Hospital and Research is valued compared to its competitors.
Global Longlife Hospital and Research PE Ratio
Global Longlife Hospital and Research PE ratio helps investors understand what is the market value of each stock compared to Global Longlife Hospital and Research 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
Global Longlife Hospital and Research PEG Ratio
The PEG ratio of Global Longlife Hospital and Research evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Global Longlife Hospital and Research ROE (Return on Equity)
Return on Equity (ROE) measures how effectively Global Longlife Hospital and Research generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Global Longlife Hospital and Research ROCE (Return on Capital Employed)
Return on Capital Employed (ROCE) evaluates the profitability of Global Longlife Hospital and Research in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Global Longlife Hospital and Research Total Debt
Total debt of Global Longlife Hospital and Research shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
Global Longlife Hospital and Research Debt to Equity Ratio
The Debt-to-Equity (DE) ratio of Global Longlife Hospital and Research compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
Global Longlife Hospital and Research CAGR (Compound Annual Growth Rate)
CAGR shows the consistent growth rate of Global Longlife Hospital and Research over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Global Longlife Hospital and Research Technical Analysis
Technical analysis of Global Longlife Hospital and Research helps investors get an insight into when they can enter or exit the stock. Key components of Global Longlife Hospital and Research Technical Analysis include:
Support Levels (S1, S2, S3)
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
Resistance Levels (R1, R2, R3)
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Global Longlife Hospital and Research shares often struggle to rise above due to selling pressure.
Global Longlife Hospital and Research Dividends
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Global Longlife Hospital and Research ’s financial health and profitability.
Global Longlife Hospital and Research Bonus Shares
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Global Longlife Hospital and Research Stock Split
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
Global Longlife Hospital and Research Financials
The financials of Global Longlife Hospital and Research provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
Global Longlife Hospital and Research Profit and Loss Statements
The profit and loss statement of Global Longlife Hospital and Research highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Global Longlife Hospital and Research .
Global Longlife Hospital and Research Balance Sheet
The balance sheet presents a snapshot of Global Longlife Hospital and Research ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Global Longlife Hospital and Research Cashflow Statements
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.
SEBI REGISTERED RESEARCH ANALYST REGISTRATION NUMBER: INH000015729Disclaimer: "Investments in securities are subject to market risks. Read all the related documents carefully before investing." Receiving registration from SEBI and certification from NISM does not assure the performance of the intermediary or guarantee returns to investors in any manner. Compliance/Complaints Email: [email protected]
Features
Portfolio Analysis
Screener
Stock compare
Buckets
Watchlist
Superstar Portfolio
Market
List of BSE200 Companies
List of NIFTY500 Companies
List of NIFTY NEXT 50 Companies
NIFTY Top gainers in 5 Days
NIFTY100 Most Active Stocks
NIFTY Top Gainers in 1 Month